Activist Investing LLC's Form 4 filing
Titan Pharmaceuticals Inc (TTNP) · filed Jul 8, 2022
- Accession no.
- 0001829126-22-014209
- Filed
- Jul 8, 2022, 6:00 PM ET
- Trade date
- Jul 6-7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $1.92M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Activist Investing LLCCIK 0001817604 | Other: Member of 10% owner group |
| Lazar David E.CIK 0001932843 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2022 | Common Stock, par value $0.001 | PPurchaseAcquired | +1,165,975 | $0.7735F3 | +$901,881.66 | 2,587,108 | Direct | |
| Jul 7, 2022 | Common Stock, par value $0.001 | PPurchaseAcquired | +744,294 | $0.9929F4 | +$739,009.51 | 3,331,402 | Direct | |
| Jul 6, 2022 | Common Stock, par value $0.001 | PPurchaseAcquired | +315,921 | $0.8926F6 | +$281,991.08 | 359,066 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.5982 to $0.9964. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.8399 to $1.1000. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F6
Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.6640 to $0.9499. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.